T. Kataoka
Cold Spring Harbor Laboratory
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by T. Kataoka.
Cell | 1985
T. Toda; Isao Uno; Tatsuo Ishikawa; Scott Powers; T. Kataoka; Daniel Broek; S. Cameron; James R. Broach; Kunihiro Matsumoto; Michael Wigler
S. cerevisiae strains containing RAS2val19, a RAS2 gene with a missense mutation analogous to one that activates the transforming potential of mammalian ras genes, have growth and biochemical properties strikingly similar to yeast strains carrying IAC or bcy1. Yeast strains carrying the IAC mutation have elevated levels of adenylate cyclase activity. bcy1 is a mutation that suppresses the lethality in adenylate cyclase deficient yeast. Yeast strains deficient in RAS function exhibit properties similar to adenylate cyclase deficient yeast. bcy1 suppresses lethality in ras1- ras2- yeast. Compared to wild-type yeast strains, intracellular cyclic AMP levels are significantly elevated in RAS2val19 strains, significantly depressed in ras2- strains, and virtually undetectable in ras1- ras2- bcy1 strains. Membranes from ras1- ras2- bcy1 yeast lack the GTP-stimulated adenylate cyclase activity present in membranes from wild-type cells, and membranes from RAS2val19 yeast strains have elevated levels of an apparently GTP-independent adenylate cyclase activity. Mixing membranes from ras1- ras2- yeast with membranes from adenylate cyclase deficient yeast reconstitutes a GTP-dependent adenylate cyclase.
Cell | 1984
T. Kataoka; Scott Powers; Carolyn McGill; O. Fasano; Jeffrey N. Strathern; James R. Broach; Michael Wigler
We present a genetic analysis of RAS1 and RAS2 of S. cerevisiae, two genes that are highly homologous to mammalian ras genes. By constructing in vitro ras genes disrupted by selectable genes and introducing these by gene replacement into the respective ras loci, we have determined that neither RAS1 nor RAS2 are by themselves essential genes. However, ras1 - ras2 - spores of doubly heterozygous diploids are incapable of resuming vegetative growth. We have determined that RAS1 is located on chromosome XV, 7 cM from ade2 and 63 cM from his3; and RAS2 is located on chromosome XIV, 2 cM from met4 . We have also constructed by site-directed mutagenesis a missense mutant, RAS2val19 , which encodes valine in place of glycine at the nineteenth amino acid position, the same sort of missense mutation that is found in some transforming alleles of mammalian ras genes. Diploid yeast cells that contain this mutation are incapable of sporulating efficiently, even when they contain wild-type alleles.
Cell | 1985
T. Kataoka; Daniel Broek; Michael Wigler
We have cloned CYR1, the S. cerevisiae gene encoding adenylate cyclase. The DNA sequence of CYR1 can encode a protein of 2026 amino acids. This protein would contain a central region comprised of over twenty copies of a 23 amino acid repeating unit with remarkable homology to a 24 amino acid tandem repeating unit of a trace human serum glycoprotein. Gene disruption and biochemical experiments indicate that the catalytic domain of adenylate cyclase resides in the carboxyl terminal 400 amino acids. Elevated expression of adenylate cyclase suppresses the lethality that otherwise results from loss of RAS gene function in yeast. Yeast adenylate cyclase, made in E. coli, cannot be activated by added RAS protein.
Cell | 1984
Scott Powers; T. Kataoka; O. Fasano; Mitchell Goldfarb; J. Strathem; James R. Broach; Michael Wigler
The ras genes, which were first identified by their presence in RNA tumor viruses and which belong to a highly conserved gene family in vertebrates, have two close homologs in yeast, detectable by Southern blotting. We have cloned both genes (RAS1 and RAS2) from plasmid libraries and determined the complete nucleotide sequence of their coding regions. They encode proteins with nearly 90% homology to the first 80 positions of the mammalian ras proteins, and nearly 50% homology to the next 80 amino acids. Yeast RAS1 and RAS2 proteins are more homologous to each other, with about 90% homology for the first 180 positions. After this, at nearly the same position that the mammalian ras proteins begin to diverge from each other, the two yeast ras proteins diverge radically. The yeast ras proteins, like the proteins encoded by the mammalian genes, terminate with the sequence cysAAX, where A is an aliphatic amino acid. Thus the yeast ras proteins have the same overall structure and interrelationship as the family of mammalian ras proteins. The domains of divergence may correspond to functional domains of the ras proteins. Monoclonal antibody directed against mammalian ras proteins immunoprecipitates protein in yeast cells containing high copy numbers of the yeast RAS2 gene.
Cell | 1985
T. Kataoka; Scott Powers; S. Cameron; O. Fasano; Mitchell Goldfarb; James R. Broach; Michael Wigler
Yeast spores lacking endogenous RAS genes will not germinate. If such spores contain chimeric mammalian/yeast RAS genes or even the mammalian H-ras gene under the control of the galactose-inducible GAL10 promoter, they will germinate in the presence of galactose and produce viable haploid progeny dependent on galactose for continued growth and viability. These results indicate that the biochemical function of RAS proteins is essential for vegetative haploid yeast and that this function has been conserved in evolution since the progenitors of yeast and mammals diverged.
Cell | 1990
J. Field; Anne Vojtek; R. Ballester; G. Bolger; J. Colicelli; K. Ferguson; Jeffrey E. Gerst; T. Kataoka; T. Michaeli; Scott Powers; Michael Riggs; Linda Rodgers; I. Wieland; B. Wheland; Michael Wigler
Adenylyl cyclase from S. cerevisiae contains at least two subunits, a 200 kd catalytic subunit and a subunit with an apparent molecular size of 70 kd, which we now call CAP (cyclase-associated protein). We cloned a cDNA encoding CAP by screening a yeast cDNA expression library in E. coli with antisera raised against the purified protein. The cDNA contained an open reading frame capable of encoding a 526 amino acid protein that is not homologous to any sequences in the current data bases. Adenylyl cyclase activity in membranes from cells that lacked CAP was not stimulated by RAS2 proteins in vitro. These results suggest that CAP is required for at least some aspects of the RAS-responsive signaling system. Mutants lacking CAP had four additional phenotypes that appear to be unrelated to effects of the RAS/adenylyl cyclase pathway: the inability to grow on rich medium (YPD), temperature sensitivity on minimal medium, sensitivity to nitrogen starvation, and a swollen cell morphology.
Molecular and Cellular Biology | 1987
J. Field; Daniel Broek; T. Kataoka; Michael Wigler
In the yeast Saccharomyces cerevisiae, yeast RAS proteins are potent activators of adenylate cyclase. In the present work we measured the activity of adenylate cyclase in membranes from Saccharomyces cerevisiae which overexpress this enzyme. The response of the enzyme to added RAS2 proteins bound with various guanine nucleotides and their analogs suggests that RAS2 proteins are active in their GTP-bound form and are virtually inactive in their GDP-bound form. Also, active RAS2 protein is not inhibited by inactive RAS2, suggesting that the inactive form does not compete with the active form in binding to its effector.
Cold Spring Harbor Symposia on Quantitative Biology | 1985
C. Birchmeier; Daniel Broek; T. Toda; Scott Powers; T. Kataoka; Michael Wigler
The ras genes were first isolated as the transforming genes of Harvey and Kirsten sarcoma virus (Ellis et al. 1981). At least three different ras genes, Ha-ras, Ki-ras, and N-ras, exist in mammals and code for three very similar 21-kD proteins (Shimizu et al. 1983b). The ras proteins are localized in the plasma membrane (Willingham et al. 1980), bind guanine nucleotides (Shih et al. 1980, 1982), and have weak GTPase activity (Gibbs et al. 1984; McGrath et al. 1984; Sweet et al. 1984). A large number of tumor cells contain structurally mutated ras genes that are capable of tumorigenic transformation of NIH-3T3 cells upon DNA-mediated gene transfer (Reddy et al. 1982; Tabin et al. 1982; Taparowsky et al. 1982; Capon et al. 1983; Shimizu et al. 1983a; Yuasa et al. 1983)
Archive | 1984
Scott Powers; T. Kataoka; O. Fasano; Mitchell Goldfarb; Jeffrey N. Strathern; James R. Broach; Michael Wigler
Archive | 1984
Michael Wigler; O. Fasano; Elizabeth J. Taparowsky; Scott Powers; T. Kataoka; Daniel Birnbaum; K. Shimizu; Mitchell Goldfarb